Pozen

基本解釋

Mr Pozen's new book, “Too Big to Save?
波曾的新書“太大而不能拯救？”
POZEN Inc and GlaxoSmithKline Inc, the maker of sumatriptan, supported this study and employ 4 of its authors.
作為舒馬曲坦的制造公司，Pozen公司和葛蘭素史克公司支持了這項(xiàng)研究并且雇用了其中的4名作者。
Other authors hae disclosed arious releant financial relationships with GlaxoSmithKline Inc and/or POZEN Inc.
其它作者透漏了葛蘭素史克公司和/或Pozen公司的各種相關(guān)的經(jīng)濟(jì)支持。
Pozen identified other signs that U.S. accounting rules are too complex, starting with the large number of companies that each year restate previously issued earnings.
當(dāng)年的安然公司主要通過復(fù)雜的、未入帳的交易來達(dá)到隱藏其日益增加的負(fù)債的目的，這最終導(dǎo)致了安然公司的會(huì)計(jì)丑聞。
Mr Pozen takes an unusual stand on an issue his former committee ducked completely: whether American companies should adopt international accounting rules.
波曾站在與他以前的委員會(huì)完全不同的不尋常的立場(chǎng)：美國(guó)公司是否應(yīng)采取國(guó)際會(huì)計(jì)準(zhǔn)則。